JOHN WOYTOWICZ: Open Payments
NPI 1205802212 · AUBURN, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$470 in 21 payments from 14 companies in 2025. Trend: 2023 $438 · 2024 $1,596 · 2025 $470
Food & beverage: $470
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $86 |
| Amgen Inc. | 3 | $79 |
| Axsome Therapeutics, Inc. | 2 | $53 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| ABBVIE INC. | 1 | $32 |
| Exact Sciences Corporation | 1 | $27 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Astellas Pharma US Inc | 1 | $24 |
| PFIZER INC. | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
Products named: BREZTRI, OTEZLA, Auvelity, SHINGRIX, UBRELVY, AIRSUPRA, Cologuard Collection Kit, REXULTI.
Industry payments across ME — which companies pay providers there.
